The DOI matches its Crossref record; 34 of the 36 references it cites were found in a registry or an index.
Presynaptic nicotinic receptors modulating dopamine release in the rat striatum
Abstract
The modulation of striatal dopamine release by presynaptic nicotinic acetylcholine receptors is well documented for both synaptosomes and slices. Because the latter retain local anatomical integrity, we have compared [3H]dopamine release evoked by the nicotinic receptor agonists (-)-nicotine and (+/-)-anatoxin-a from striatal synaptosome and slice preparations in parallel. At higher agonist concentrations, mecamylamine-sensitive [3H]dopamine release was greater from slices, indicative of an additional component, and this increase was abolished by glutamate receptor antagonists. To begin to examine the localisation of specific nicotinic acetylcholine receptor subtypes in the striatum, immunogold electron microscopy was undertaken with the beta2-specific monoclonal antibody 270. In striatal sections, gold particles were associated with symmetric synapses (dopaminergic) but were absent from asymmetric synapses (glutamatergic). Surface labelling of striatal synaptosomes with gold particles was also demonstrated. Taken together, these results are consistent with dopamine release mediated by beta2-containing nicotinic acetylcholine receptors on dopamine terminals, while non-beta2-containing nicotinic acetylcholine receptors may enhance dopamine release indirectly by releasing glutamate from neighbouring terminals.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, nicotine has a cascading effect on central neurotransmission also resulting in the release of norepinephrine and histamine as well as GABA and glutamate (28, 29).”
From The detrimental effects of smoking on the course and outcome in adults with bipolar disorder—A narrative review (2023) · cites this paper as [29]
Citations
Cites
THE USE OF LEAD CITRATE AT HIGH pH AS AN ELECTRON-OPAQUE STAIN IN ELECTRON MICROSCOPY
Reynolds, E. S. (1963) · The Journal of Cell Biology · doi:10.1083/jcb.17.1.208 · Cited by 24,938
Picciotto, M. R., Zoli, M., Rimondini, R., Léna, C., Marubio, L. M., Pich, E. M., Fuxe, K., & Changeux, J.-P. (1998) · Nature · doi:10.1038/34413 · Cited by 1,320
Presynaptic nicotinic ACh receptors
Wonnacott, S. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)10073-4 · Cited by 1,308
Self-citationNicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors
McGehee, D. S., Heath, M. J. S., Gelber, S., Devay, P., & Role, L. W. (1995) · Science · doi:10.1126/science.7569895 · Cited by 1,070
Smith, A. D., & Bolam, J. P. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90106-k · Cited by 1,040
Hippocampal synaptic transmission enhanced by low concentrations of nicotine
Gray, R. G. F., Rajan, A. S., Radcliffe, K. A., Yakehiro, M., & Dani, J. A. (1996) · Nature · doi:10.1038/383713a0 · Cited by 947
Baude, A., Nusser, Z., Roberts, J. D. B., Mulvihill, E., Jeffrey Mcllhinney, R. A., & Somogyi, P. (1993) · Neuron · doi:10.1016/0896-6273(93)90086-7 · Cited by 927
Nicotinic Receptors in the Development and Modulation of CNS Synapses
Role, L. W., & Berg, D. K. (1996) · Neuron · doi:10.1016/s0896-6273(00)80134-8 · Cited by 762
A simple apparatus for studying the release of neurotransmitters from synaptosomes
Raiteri, M., Angelini, F., & Levi, G. (1974) · European Journal of Pharmacology · doi:10.1016/0014-2999(74)90272-6 · Cited by 459
Dunkley, P. R., Heath, J. W., Harrison, S. M., Jarvie, P. E., Glenfield, P. J., & Rostas, J. A. P. (1988) · Brain Research · doi:10.1016/0006-8993(88)91383-2 · Cited by 365
Research works printed but not linked: 2
- Grady, 1998, Nicotine stimulated synaptosomal neurotransmitter release from beta-2 null mutant mice, Soc. Neurosci. Abstr., 24, 1342
- Kaiser, 1998, Nicotinic receptor modulation of neurotransmitter release, Vol. 8, 141
Cited by
Sorted by citations
Pierce, R. C., & Kumaresan, V. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.04.016 · Cited by 913
Nicotinic acetylcholine receptors: from structure to brain function
Hogg, R. C., Raggenbass, M., & Bertrand, D. (2003) · Springer eBooks · doi:10.1007/s10254-003-0005-1 · Cited by 536
Cachope, R., Mateo, Y., Mathur, B. N., Irving, J. M., Wang, H., Morales, M., Lovinger, D. M., & Cheer, J. F. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.05.011 · Cited by 529
Neurotransmitter roles in synaptic modulation, plasticity and learning in the dorsal striatum
Lovinger, D. M. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.01.008 · Cited by 488
“It is well established that presynaptic nAChRs on dopaminergic terminals can stimulate dopamine release in striatum, and these LGICs have been implicated in stimulation-induced release of dopamine (Giorguieff et al., 1976; Kulak et al., 1997; Wonnacott et al., 2000; Zhou et al., 2001).”
It could be habit forming: drugs of abuse and striatal synaptic plasticity
Gerdeman, G. L., Partridge, J. G., Lupica, C. R., & Lovinger, D. M. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(03)00065-1 · Cited by 480
Striatal dopamine neurotransmission: Regulation of release and uptake
Sulzer, D., Cragg, S. J., & Rice, M. E. (2016) · Basal Ganglia · doi:10.1016/j.baga.2016.02.001 · Cited by 382
Reward, addiction, withdrawal to nicotine
De Biasi, M., & Dani, J. A. (2011) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113734 · Cited by 366
“The ongoing activity of striatal cholinergic interneurons (Bennett & Wilson 1999) excites presynaptic nAChRs on the DA terminals (Jones et al. 2001), producing an increase of intraterminal calcium that enhances DA release (Grady et al. 1997, Wonnacott et al. 2000).”
BackgroundWooltorton, J. R. A., Pidoplichko, V. I., Broide, R. S., & Dani, J. A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-08-03176.2003 · Cited by 363
Calabresi, P., Picconi, B., Parnetti, L., & Filippo, M. D. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70600-7 · Cited by 343
Couey, J. J., Meredith, R. M., Spijker, S., Poorthuis, R. B., Smit, A. B., Brussaard, A. B., & Mansvelder, H. D. (2007) · Neuron · doi:10.1016/j.neuron.2007.03.006 · Cited by 253
Exley, R. A., & Cragg, S. J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707510 · Cited by 271
Barr, R. S., Maravić, M. C., Jubelt, L. E., Mufti, R. S., Dyer, M. A., Weiss, A. P., Deckersbach, T., Kelly, J. F., Freudenreich, O., GOFF, D. C., et al. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301423 · Cited by 242
Striatal cholinergic interneuron regulation and circuit effects
Lim, S. A. O., Kang, U. J., & McGehee, D. S. (2014) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2014.00022 · Cited by 244
Jones, C. K., Byun, N. E., & Bubser, M. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.199 · Cited by 241
Kaiser, S., & Wonnacott, S. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.2.312 · Cited by 218
Self-citationPresynaptic regulation of dopaminergic neurotransmission
Schmitz, Y., Benoit‐Marand, M., Gonon, F., & Sulzer, D. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02050.x · Cited by 202
Pidoplichko, V. I., Noguchi, J., Areola, O. O., Liang, Y., Peterson, J., Zhang, T., & Dani, J. A. (2004) · Learning & Memory · doi:10.1101/lm.70004 · Cited by 196
Dopamine Signaling in Dorsal Versus Ventral Striatum: The Dynamic Role of Cholinergic Interneurons
Threlfell, S., & Cragg, S. J. (2011) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2011.00011 · Cited by 200
Neuronal nicotinic receptors: from protein structure to function
Itier, V., & Bertrand, D. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02702-8 · Cited by 190
Gonzales, K. K., & Smith, Y. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12762 · Cited by 175
Jones, I. W., Bolam, J. P., & Wonnacott, S. (2001) · The Journal of Comparative Neurology · doi:10.1002/cne.1345 · Cited by 168
Self-citationDopamine Signaling Differences in the Nucleus Accumbens and Dorsal Striatum Exploited by Nicotine
Zhang, T., Zhang, L., Liang, Y., Siapas, A. G., Zhou, F.-M., & Dani, J. A. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.0261-09.2009 · Cited by 170
Genetics of nicotinic acetylcholine receptors: Relevance to nicotine addiction
Mineur, Y. S., & Picciotto, M. R. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.06.010 · Cited by 139
Levin, E. D., & Rezvani, A. H. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.019 · Cited by 129
Partridge, J. G., Apparsundaram, S., Gerhardt, G. A., Ronesi, J. A., & Lovinger, D. M. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-07-02541.2002 · Cited by 130
Testai, E., Scardala, S., Vichi, S., Buratti, F. M., & Funari, E. (2016) · Critical Reviews in Toxicology · doi:10.3109/10408444.2015.1137865 · Cited by 127
Zhang, H., & Sulzer, D. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-33-10585.2003 · Cited by 125
Nicotinic acetylcholine receptors: Conventional and unconventional ligands and signaling
Papke, R. L., & Lindstrom, J. M. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108021 · Cited by 128
Chronic high dose transdermal nicotine in Parkinson's disease: an open trial
Villafane, G., Césaro, P., Rialland, A., Baloul, S., Azimi, S., Bourdet, C., Houezec, J. L., Macquin‐Mavier, I., & Maison, P. (2007) · European Journal of Neurology · doi:10.1111/j.1468-1331.2007.01949.x · Cited by 118
Cholinergic nervous system and glaucoma: From basic science to clinical applications
Faiq, M. A., Wollstein, G., Schuman, J. S., & Chan, K. C. (2019) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2019.06.003 · Cited by 127
Xiao, C., Nashmi, R., McKinney, S. L., Cai, H., McIntosh, J. M., & Lester, H. A. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.2939-09.2009 · Cited by 117
Lemay, S., Chouinard, S., Blanchet, P. J., Masson, H., Soland, V., Beuter, A. C., & Bédard, M. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(03)00172-6 · Cited by 99
Nucleus Accumbens Acetylcholine Receptors Modulate Dopamine and Motivation
Collins, A. L., Aitken, T. J., Greenfield, V. Y., Ostlund, S. B., & Wassum, K. M. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.81 · Cited by 97
Torres‐Altoro, M. I., Mathur, B. N., Drerup, J. M., Thomas, R. E., Lovinger, D. M., O'Callaghan, J. P., & Bibb, J. A. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07428.x · Cited by 94
Mexal, S., Frank, M., Berger, R., Adams, C. E., Ross, R. G., Freedman, R., & Leonard, S. S. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2005.06.006 · Cited by 93
Striatal cholinergic interneurons and Parkinson's disease
Tanimura, A., Pancani, T., Lim, S. A. O., Tubert, C., Melendez-Zaidi, A. E., Shen, W., & Surmeier, D. J. (2017) · European Journal of Neuroscience · doi:10.1111/ejn.13638 · Cited by 94
Assous, M., & Tepper, J. M. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.13881 · Cited by 89
Pratt, W. E., & Kelley, A. E. (2004) · Behavioral Neuroscience · doi:10.1037/0735-7044.118.4.730 · Cited by 98
Toxin-Induced and Genetic Animal Models of Parkinson's Disease
Hisahara, S., & Shimohama, S. (2010) · Parkinson s Disease · doi:10.4061/2011/951709 · Cited by 95
Nucleus Accumbens Microcircuit Underlying D2-MSN-Driven Increase in Motivation
Soares‐Cunha, C., Coimbra, B., Domingues, A. V., de Vasconcelos, N. A. P., Sousa, N., & Rodrigues, A. J. (2018) · eNeuro · doi:10.1523/eneuro.0386-18.2018 · Cited by 102
Lovinger, D. M., Partridge, J. G., & Tang, K. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.014 · Cited by 86
Excitatory and inhibitory responses of dopamine neurons in the ventral tegmental area to nicotine
Erhardt, S., Schwieler, L., & Engberg, G. (2002) · Synapse · doi:10.1002/syn.10044 · Cited by 85
Non-pharmacological factors that determine drug use and addiction
Ahmed, S. H., Badiani, A., Miczek, K. A., & Müller, C. P. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.08.015 · Cited by 85
Janhunen, S. K., & Ahtee, L. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.09.008 · Cited by 83
Quarta, D., Ciruela, F., Patkar, K. A., Borycz, J., Solinas, M., Lluı́s, C., Franco, R., Wise, R. A., Goldberg, S. R., Hope, B. T., et al. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301103 · Cited by 80
Rahman, S., & McBride, W. J. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2001.00739.x · Cited by 75
Differential regulation of dopamine D1 and D2 signaling by nicotine in neostriatal neurons
Hamada, M., Higashi, H., Nairn, A. C., Greengard, P., & Nishi, A. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02574.x · Cited by 78
Franceschini, D., Paylor, R. E., Broide, R. S., Salas, R., Bassetto, L., Gotti, C., & Biasi, M. D. (2002) · Molecular Brain Research · doi:10.1016/s0169-328x(01)00309-6 · Cited by 72
Yang, K., Hu, J., Lucero, L. M., Liu, Q., Zheng, C. J., Zhen, X., Jin, G.-Z., Lukas, R. J., & Wu, J. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2008.162743 · Cited by 77
Broide, R. S., Salas, R., Ji, D., Paylor, R. E., Patrick, J. W., Dani, J. A., & Biasi, M. D. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.3.695 · Cited by 72
Torrealba, F., Riveros, M. E., Contreras, M., & Valdés, J. L. (2012) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2012.00051 · Cited by 75
Transdermal Treatment Options for Neurological Disorders
Priano, L., Gasco, M. R., & Mauro, A. (2006) · Drugs & Aging · doi:10.2165/00002512-200623050-00001 · Cited by 71
Regulation of striatal dopamine release by presynaptic auto- and heteroreceptors
Zhang, H., & Sulzer, D. (2011) · Basal Ganglia · doi:10.1016/j.baga.2011.11.004 · Cited by 73
Tranylcypromine enhancement of nicotine self-administration
Villégier, A., Lotfipour, S., McQuown, S. C., Belluzzi, J. D., & Leslie, F. M. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.02.001 · Cited by 71
Bordia, T., McGregor, M. M., Papke, R. L., Decker, M. W., McIntosh, J. M., & Quik, M. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.09.015 · Cited by 67
Collo, G., Bono, F., Cavalleri, L., Plebani, L., Mitola, S. M. F., Pich, E. M., Millan, M. J., Zoli, M., Maskos, U., Spano, P., et al. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.084863 · Cited by 67
van Nierop, P., Bertrand, S., Munno, D. W., Gouwenberg, Y., van Minnen, J., Spafford, J. D., Syed, N. I., Bertrand, D., & Smit, A. B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508571200 · Cited by 66
Wu, J., George, A. A., Schroeder, K. M., Xu, L., Marxer-Miller, S., Lucero, L. M., & Lukas, R. J. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.070417 · Cited by 67
Acetylcholine waves and dopamine release in the striatum
Matityahu, L., Gilin, N., Sarpong, G. A., Atamna, Y., Tiroshi, L., Tritsch, N. X., Wickens, J. R., & Goldberg, J. A. (2023) · Nature Communications · doi:10.1038/s41467-023-42311-5 · Cited by 73
Crunelle, C. L., Miller, M. L., Booij, J., & van den Brink, W. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.11.001 · Cited by 66
Cognitive Deficits in Schizophrenia: Focus on Neuronal Nicotinic Acetylcholine Receptors and Smoking
Ochoa, E. L. M., & Lasalde‐Dominicci, J. A. (2007) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-007-9149-x · Cited by 64
Reduced striatal D 1 receptor binding in autosomal dominant nocturnal frontal lobe epilepsy
Fedi, M., Berkovic, S. F., Scheffer, I. E., O'Keefe, G. J., Marini, C., Mulligan, R. S., Gong, S., Tochon‐Danguy, H., & Reutens, D. C. (2008) · Neurology · doi:10.1212/01.wnl.0000316192.52731.77 · Cited by 62
Age dependent nicotinic influences over dopamine neuron synaptic plasticity
Placzek, A. N., Zhang, T. A., & Dani, J. A. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.05.014 · Cited by 61
Historical and current perspective on tobacco use and nicotine addiction
Dani, J. A., & Balfour, D. J. K. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2011.05.001 · Cited by 68
Nicotinic receptor modulation to treat alcohol and drug dependence
Rahman, S., Engleman, E. A., & Bell, R. L. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00426 · Cited by 60
Striatal Cholinergic Interneurons Are a Novel Target of Corticotropin Releasing Factor
Lemos, J. C., Shin, J. H., & Alvarez, V. A. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.0479-19.2019 · Cited by 59
A synaptomic analysis reveals dopamine hub synapses in the mouse striatum
Paget-Blanc, V., Pfeffer, M. E., Pronot, M., Lapios, P., Angelo, M., Walle, R., Cordelières, F. P., Levet, F., Claverol, S., Lacomme, S., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30776-9 · Cited by 60
Nicotinic receptors co-localize with 5-HT3 serotonin receptors on striatal nerve terminals
Nayak, S. V., Rondé, P., Spier, A. D., Lummis, S. C. R., & Nichols, R. A. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00109-x · Cited by 52
Acute nicotine changes dynorphin and prodynorphin mRNA in the striatum
Isola, R., Zhang, H., Tejwani, G. A., Neff, N. H., & Hadjiconstantinou, M. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1315-4 · Cited by 52
McCallum, S. E., Parameswaran, N., Bordia, T., McIntosh, J. M., Grady, S. R., & Quik, M. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.012773 · Cited by 52
Saldanha, C. J., Schlinger, B., Micevych, P., & Horvath, T. L. (2004) · The Journal of comparative neurology · doi:10.1002/cne.11035 · Cited by 59
Striatal cholinergic transmission. Focus on nicotinic receptors’ influence in striatal circuits
Assous, M. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15135 · Cited by 56
Wilkins, L. H., Haubner, A. J., Ayers, J. T., Crooks, P. A., & Dwoskin, L. P. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.3.1088 · Cited by 50
Cholinergic Modulation of Appetite-Related Synapses in Mouse Lateral Hypothalamic Slice
Jo, Y., Wiedl, D., & Role, L. W. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.3638-05.2005 · Cited by 50
Nicotine Effects on Mismatch Negativity in Nonsmoking Schizophrenic Patients
Inami, R., Kirino, E., Inoue, R., Suzuki, T., & Arai, H. (2007) · Neuropsychobiology · doi:10.1159/000111536 · Cited by 45
Quik, M., Mallela, A., Chin, M. C., McIntosh, J. M., Perez, X. A., & Bordia, T. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.09.006 · Cited by 45
Almeida, L. E. F., Pereira, E. F. R., Alkondon, M., Fawcett, W. P., Randall, W. R., & Albuquerque, E. X. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00157-x · Cited by 47
Behavioural Pharmacology and Neurobiology of Nicotine Reward and Dependence
Chiara, G. D. (2000) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-57079-7_24 · Cited by 44
Subtype-selective nicotinic receptor antagonists: potential as tobacco use cessation agents
Dwoskin, L. P., Sumithran, S. P., Zhu, J., Deaciuc, A. G., Ayers, J. T., & Crooks, P. A. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.10.073 · Cited by 44
Effect of neuroactive compounds on the settlement of mussel (Perna canaliculus) larvae
Young, T., Alfaro, A. C., & Robertson, J. (2011) · Aquaculture · doi:10.1016/j.aquaculture.2011.06.050 · Cited by 42
Forró, E., Árva, J., & Fülöp, F. (2001) · Tetrahedron Asymmetry · doi:10.1016/s0957-4166(01)00100-8 · Cited by 42
Wang, S., van der Vaart, A. D., Xu, Q., Seneviratne, C., Pomerleau, O. F., Pomerleau, C. S., Payne, T. J., Ma, J. Z., & Li, M. D. (2013) · Human Genetics · doi:10.1007/s00439-013-1398-9 · Cited by 41
Müller, C. P. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112672 · Cited by 45
The Endocannabinoid System: A New Molecular Target for the Treatment of Tobacco Addiction
Scherma, M., Fadda, P., Foll, B. L., Forget, B., Fratta, W., Goldberg, S. R., & Tanda, G. (2008) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152708786927859 · Cited by 43
Pakkanen, J. S., Jokitalo, E., & Tuominen, R. K. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04105.x · Cited by 41
Ward, R. J., Lallemand, F., Witte, P. D., & Dexter, D. T. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.03.003 · Cited by 38
Nucleus isthmi enhances calcium influx into optic nerve fiber terminals in Rana pipiens
Dudkin, E. A., & Gruberg, E. R. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02274-1 · Cited by 39
Schwieler, L., & Erhardt, S. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300255 · Cited by 39
Mouhape, C., Costa, G., Ferreira, M., Abin‐Carriquiry, J. A., Dajas, F., & Prunell, G. (2018) · Neurotoxicity Research · doi:10.1007/s12640-018-9931-1 · Cited by 38
Trihexyphenidyl rescues the deficit in dopamine neurotransmission in a mouse model of DYT1 dystonia
Downs, A. M., Fan, X., Donsante, C., Jinnah, H. A., & Hess, E. J. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.01.012 · Cited by 36
In vivo modulation of α7 nicotinic receptors on striatal glutamate release induced by anatoxin-A
Campos, F., Alfonso, M., & Durán, R. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.03.010 · Cited by 38
Ghrelin amplifies the nicotine-induced dopamine release in the rat striatum
Palotai, M., Bagosi, Z., Jászberényi, M., Csabafi, K., Dochnal, R., Manczinger, M., Telegdy, G., & Szabó, G. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.06.014 · Cited by 37
The Cholinergic System as a Treatment Target for Opioid Use Disorder
Jensen, K. P., DeVito, E. E., Yip, S. W., Carroll, K. M., & Sofuoglu, M. (2018) · CNS Drugs · doi:10.1007/s40263-018-0572-y · Cited by 37
Mutations of the neuronal nicotinic acetylcholine receptors and their association with ADNFLE
Itier, V., & Bertrand, D. (2002) · Neurophysiologie Clinique · doi:10.1016/s0987-7053(02)00294-0 · Cited by 36
Nicotinic-antipsychotic drug interactions and cognitive function
Levin, E. D., & Rezvani, A. H. (2006) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-7772-4_10 · Cited by 36
Capó-Vélez, C. M., Morales‐Vargas, B., García-González, A. P., Grajales‐Reyes, J. G., Delgado‐Vélez, M., Madera, B., Báez-Pagán, C. A., Quesada, O., & Lasalde‐Dominicci, J. A. (2018) · Scientific Reports · doi:10.1038/s41598-018-20271-x · Cited by 33
Crucial Role of Dopamine D2 Receptor Signaling in Nicotine-Induced Conditioned Place Preference
Wilar, G., Shinoda, Y., Sasaoka, T., & Fukunaga, K. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1635-x · Cited by 34
Scholze, P., Orr‐Urtreger, A., Changeux, J., McIntosh, J. M., & Huck, S. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707236 · Cited by 31
Nuutinen, S., Ahtee, L., & Tuominen, R. K. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.04.003 · Cited by 33
Shin, M., & Venton, B. J. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b02114 · Cited by 32
Metadata
- Authors
- Wonnacott, S., Kaiser, S., Mogg, A., Soliakov, L., & Jones, I. W.
- Affiliations
- University of Bath (GB)
- Corresponding author
- Wonnacott, Susan
- Venue
- European Journal of Pharmacology
- Publisher
- Elsevier BV
- Published
- 2000-03
- Volume
- 393
- Issue
- 1-3
- Pages
- 51-58
- ISSN
- 0014-2999 (ISSN-L)
- OpenAlex
- W2023915778
- Cited by
- 232
- References
- 36
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 3 · 2023: 3 · 2022: 9 · 2021: 3 · 2020: 7 · 2019: 6 · 2018: 18 · 2017: 3 · 2016: 5 · 2015: 7 · 2014: 8 · 2013: 6 · 2012: 8
- FWCI
- 4.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Oxford
- Biotechnology and Biological Sciences Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Keywords
- presynaptic nicotinic acetylcholine receptors, dopamine release, striatum, anatoxin-a, mecamylamine, synaptosomes, brain slices, glutamate release, glutamate receptor antagonists, dopaminergic terminals, immunogold electron microscopy, nicotinic receptor subtypes
- MeSH terms
- Animals, Corpus Striatum, Dopamine, Immunohistochemistry, Male, Receptors, Nicotinic, Synaptosomes, Tritium, Rats, Sprague-Dawley, Receptors, Presynaptic, Nicotinic Agonists, Rats, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review